These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 13560198)

  • 1. [Serum transaminase activity in functional and organic acroangiopathy].
    BARONE G
    Arch Sci Med (Torino); 1958 May; 105(5):421-34. PubMed ID: 13560198
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum transaminase activity in peripheral ischemic syndromes.
    BRAUNER R; SORIN E; CONSTANTINESCU A
    Med Interna (Bucur); 1958 Jan; 10(1):85-92. PubMed ID: 13516090
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of glutamic-oxalacetic and pyruvic transaminase activity in the serum of patients with chronic obliterating arterial diseases].
    AZZINI CA; GHISELLINI F
    Chir Organi Mov; 1961 Nov; 50():368-72. PubMed ID: 13863594
    [No Abstract]   [Full Text] [Related]  

  • 4. Glutamic oxalacetic transaminase and glutamic pyruvic transaminase in acute and chronic peripheral artery occlusion--an experimental study.
    MATHUR KS; JAITLEY DK
    Indian Heart J; 1961 Apr; 13():107-13. PubMed ID: 13768141
    [No Abstract]   [Full Text] [Related]  

  • 5. Glutamic oxalacetic transaminase in chronic and acute peripheral artery occlusion; clinical and experimental study.
    FERUGLIO GA; BELLET S; FEINBERG LJ
    Am J Cardiol; 1959 Aug; 4(2):211-7. PubMed ID: 13670123
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behavior of certain enzymatic activities in the course of ischemic syndromes due to obstructive arteriopathies of the lower extremities (aspartic & alanine-ketoglutaric transaminases, phosphoglucomutases)].
    DI SIMONE A; FERRANTE G
    Minerva Chir; 1959 Feb; 14(3):123-7. PubMed ID: 13656561
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biochemical research on venous blood of extremities in obliterative vascular lesions. V. Transaminases].
    GIBINSKI K; KOKOT F
    Pol Arch Med Wewn; 1958; 28(5):687-92. PubMed ID: 13601307
    [No Abstract]   [Full Text] [Related]  

  • 8. [Differences in serum cholinesterase and serum glutamic oxalacetic transaminase activity in liver diseases].
    PIETSCHMANN H
    Wien Z Inn Med; 1960 Oct; 41():409-14. PubMed ID: 13735630
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum glutamic oxalacetic transaminase activity in various diseases.
    MIYAKAZE Y; CARSTENS HP
    Ill Med J; 1959 Jul; 116(1):1-8. PubMed ID: 13664317
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of the serum LDH activity in peripheral circulatory disorders].
    POKORNY J; STUCHLIKOVA E; TENOROVA M; SINDELAROVA I
    Cas Lek Cesk; 1961 Jul; 100():913-6. PubMed ID: 13736620
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in aminoaciduria and serum transaminase activity after parenteral administration of vitamin B6].
    CORSINI F
    Clin Pediatr (Bologna); 1958 May; 40(5):410-6. PubMed ID: 13573633
    [No Abstract]   [Full Text] [Related]  

  • 12. [Behavior of serum transaminase activity in surgical disease patients].
    D'ABBICCO V; DE TULLIO A
    Acta Chir Ital; 1958; 14(4):539-51. PubMed ID: 13570866
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on beta-glucuronidase. II. Clinical application of the assay method of beta-glucuronidase activity using p-nitrophenylglucuronide as the substrate. III. The significance of the serum beta-glucuronidase activity in patients with liver diseases, with special references to its relation with the serum transaminase activity, and to its characteristic behavior in cholangiolitic hepatitis].
    NOBUNAGA M
    Fukuoka Igaku Zasshi; 1961 Apr; 52():300-11. PubMed ID: 13729379
    [No Abstract]   [Full Text] [Related]  

  • 14. [Transaminase activity of the protein fractions of blood serum].
    SEVELA M
    Cas Lek Cesk; 1958 Oct; 97(40):1255-7. PubMed ID: 13608454
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical significance of changes in transaminase activity of serum].
    WROBLEWSKI F; LEVITAN R
    Harefuah; 1957 Dec; 53(12):317-20 passim. PubMed ID: 13501693
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum transaminase activity in surgical patients].
    HURME K; HAIKONEN M
    Duodecim; 1957; 73(9):540-3. PubMed ID: 13480223
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of opiates on the activity of serum transaminase.
    FOULK WT; FLEISHER GA
    Proc Staff Meet Mayo Clin; 1957 Aug; 32(16):405-10. PubMed ID: 13465819
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum glutamic oxalacetic transaminase activity in experimental burns.
    ARTURSON G
    Acta Chir Scand; 1961 Jan; 120():303-8. PubMed ID: 13684587
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of changes in serum transaminase activity].
    ERSBAK J
    Nord Med; 1959 Jan; 61(2):49-54. PubMed ID: 13623048
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experiences with the measurement of serum transaminase activity].
    TENYI M
    Orv Hetil; 1958 Aug; 99(35):1207-9. PubMed ID: 13600777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.